BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38132573)

  • 1. Patterns and Outcomes of Acute Central Nervous System Complications During Treatment of Childhood Acute Lymphoblastic Leukemia: A Single-center Experience.
    Hamoda A; Bedair M; Semary SF; Youssef A; Hafez H
    J Pediatr Hematol Oncol; 2024 Mar; 46(2):72-79. PubMed ID: 38132573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Complications in the central nervous system during chemotherapy for childhood acute lymphoblastic leukemia: JACLS ALL-02 study].
    Umeda K; Yoshida M; Suzuki N; Endo M; Sato A; Hori H; Isogai M; Matsumoto K; Hara JI; Hasegawa D; Hashii Y; Chayama K; Miyaji R; Nishimura S; Tanizawa A; Uami I; Horibe K; Wakazono Y; Yagi K
    Rinsho Ketsueki; 2007 Mar; 48(3):204-11. PubMed ID: 17441477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central nervous system complications during treatment of acute lymphoblastic leukemia in a single pediatric institution.
    Parasole R; Petruzziello F; Menna G; Mangione A; Cianciulli E; Buffardi S; Marchese L; Nastro A; Misuraca A; Poggi V
    Leuk Lymphoma; 2010 Jun; 51(6):1063-71. PubMed ID: 20470218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
    Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
    Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute Central Nervous System Complications in Pediatric Acute Lymphoblastic Leukemia.
    Baytan B; Evim MS; Güler S; Güneş AM; Okan M
    Pediatr Neurol; 2015 Oct; 53(4):312-8. PubMed ID: 26202590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia during remission induction chemotherapy: a single-center retrospective study.
    Lin W; Xie J; Zhang J; Cheng H; Cui H; Zhang Y; Wu Y; Yu J; Qi P; Fan J; Gao H; Wang F; Zhang R; Zheng H
    Minerva Pediatr (Torino); 2023 Dec; 75(6):808-816. PubMed ID: 31729207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The spectrum of acute central nervous system symptoms during the treatment of childhood acute lymphoblastic leukaemia.
    Banerjee J; Niinimäki R; Lähteenmäki P; Hed Myrberg I; Arola M; Riikonen P; Lönnqvist T; Palomäki M; Ranta S; Harila-Saari A; Taskinen M
    Pediatr Blood Cancer; 2020 Feb; 67(2):e27999. PubMed ID: 31674724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Posterior reversible encephalopathy syndrome in children with acute lymphoblastic leukemia: Clinical characteristics, risk factors, course, and outcome of disease.
    Anastasopoulou S; Eriksson MA; Heyman M; Wang C; Niinimäki R; Mikkel S; Vaitkevičienė GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Harila-Saari A; Ranta S
    Pediatr Blood Cancer; 2019 May; 66(5):e27594. PubMed ID: 30592147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute central nervous system toxicity during treatment of pediatric acute lymphoblastic leukemia: phenotypes, risk factors and genotypes.
    Anastasopoulou S; Nielsen RL; Als-Nielsen B; Banerjee J; Eriksson MA; Helenius M; Heyman MM; Johannsdottir IM; Jonsson OG; MacGregor S; Mateos MK; Mayoh C; Mikkel S; Myrberg IH; Niinimäki R; Schmiegelow K; Taskinen M; Vaitkeviciene G; Warnqvist A; Wolthers B; Harila-Saari A; Ranta S
    Haematologica; 2022 Oct; 107(10):2318-2328. PubMed ID: 35354251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study.
    Guzelkucuk Z; Karapınar DY; Gelen SA; Tokgoz H; Ozcan A; Ay Y; Bahadır A; Ozbek NY; Oren AC; Ayhan AC; Akyay A; Akıncı B; Karadas N; Unuvar A; Oren H; Fettah A; Kaya Z; Isık B; Eker İ; Karaman S; Yıldırım AT; Orhan MF; Oymak Y; Timur C; Yazici N; Simsek A; Karakurt N; Toret E; Evim MS
    Pediatr Blood Cancer; 2023 Aug; 70(8):e30425. PubMed ID: 37194482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of treatment of lymphoblastic lymphoma at the children cancer hospital Egypt - A single center experience.
    Rahman Sayed HA; Sedky M; Hamoda A; Kinaaie NE; Wakeel ME; Hesham D
    J Egypt Natl Canc Inst; 2016 Sep; 28(3):175-81. PubMed ID: 27339800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
    Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
    J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute neurological complications during acute lymphoblastic leukemia therapy: A single-center experience over 10 years.
    Rahiman EA; Rajendran A; Sankhyan N; Singh P; Muralidharan J; Bansal D; Trehan A
    Indian J Cancer; 2021; 58(4):545-552. PubMed ID: 34380827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seizures during treatment of childhood acute lymphoblastic leukemia: A population-based cohort study.
    Anastasopoulou S; Heyman M; Eriksson MA; Niinimäki R; Taskinen M; Mikkel S; Vaitkeviciene GE; Johannsdottir IM; Myrberg IH; Jonsson OG; Als-Nielsen B; Schmiegelow K; Banerjee J; Ranta S; Harila-Saari A
    Eur J Paediatr Neurol; 2020 Jul; 27():72-77. PubMed ID: 32340855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival outcome following isolated central nervous system relapse treated with additional chemotherapy and craniospinal irradiation in childhood acute lymphoblastic leukemia.
    Kumar P; Kun LE; Hustu HO; Mulhern RK; Hancock ML; Coffey D; Rivera GK
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):477-83. PubMed ID: 7852109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posterior Reversible Encephalopathy Syndrome: Risk Factors and Impact on the Outcome in Children With Acute Lymphoblastic Leukemia Treated With Nordic Protocols.
    Banerjee JS; Heyman M; Palomäki M; Lähteenmäki P; Arola M; Riikonen PV; Möttönen MI; Lönnqvist T; Taskinen MH; Harila-Saari AH
    J Pediatr Hematol Oncol; 2018 Jan; 40(1):e13-e18. PubMed ID: 29200159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The results of the modified St Jude Total Therapy XV Protocol in the treatment of low- and middle-income children with acute lymphoblastic leukemia.
    Yilmaz B; Koc A; Dogru O; Tufan Tas B; Senay RE
    Leuk Lymphoma; 2023; 64(7):1304-1314. PubMed ID: 37165575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma.
    Vagace JM; de la Maya MD; Caceres-Marzal C; Gonzalez de Murillo S; Gervasini G
    Crit Rev Oncol Hematol; 2012 Nov; 84(2):274-86. PubMed ID: 22578745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and risk factors for Central Nervous System thrombosis in paediatric acute lymphoblastic leukaemia during intensive asparaginase treatment: a single-centre cohort study.
    Duarte X; Esteves S; Neto AM; Pereira F
    Br J Haematol; 2016 Jul; 174(2):280-91. PubMed ID: 27018199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study.
    Mahoney DH; Shuster JJ; Nitschke R; Lauer SJ; Steuber CP; Winick N; Camitta B
    J Clin Oncol; 1998 May; 16(5):1712-22. PubMed ID: 9586883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.